Mechanisms of airway inflammation in severe/refractory asthma

Mechanisms of airway inflammation in severe/refractory asthma - Airway inflammation in severe asthma

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008401

Enrollment

Registered

2012-07-11

Start date

2012-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchial asthma

Interventions

Anti-inflammatory drugs (e.g. Systemic corticosteroids)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: severe asthma defined by the American Thoracic S0ciety Criteria

Exclusion criteria

Exclusion criteria: Respiratory failure Subjects at exacerbations of asthma

Design outcomes

Primary

Measure	Time frame
Airway inflammation Lung function Asthma symptom Activity	—

Countries

Japan

Contacts

Public ContactKazuto Matsunaga

Wakayama Medical University Third Department of Internal Medicine

kazmatsu@wakayama-med.ac.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026